Gold Member Since 2016
Nanjing Bangnuo Biotechnology Co., Ltd.

Fujimycin, API, Pharmaceuticals manufacturer / supplier in China, offering Anti-Inflammatory Pharmaceutical Intermediates Immunosuppressor 104987-11-3 Tacrolimus, Anabolic Steroid Powder CAS 2590-41-2 Dehydronandrolone Acetate, Anti-Inflammatory Pharmaceutical Raw Material CAS 104987-11-3 Tacrolimus and so on.

(/ )

Supplier Homepage Product Active Pharmaceutical Ingredients Pharmaceutical Raw Materials Anti-Inflammatory Pharmaceutical Intermediates Immunosuppressor 104987-11-3 Tacrolimus

Anti-Inflammatory Pharmaceutical Intermediates Immunosuppressor 104987-11-3 Tacrolimus

Purchase Qty.:
(g)
10-99 100-999 1,000+
FOB Unit Price: US $8 US $5 US $3
Purchase Qty. (g) FOB Unit Price
10-99 US $8
100-999 US $5
1,000+ US $3
Get Latest Price
Port: Hong Kong, Hong Kong
Production Capacity: 1500kg/Month
Payment Terms: T/T, Western Union, Money Gram, Bitcoin

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: 104987-11-3
  • Customized: Non-Customized
  • Suitable for: Elderly, Children, Adult
  • Purity: >99%
  • CAS: 104987-11-3
  • Transport Package: 1kg/Foil Bag
  • Origin: Made in China
  • Powder: Yes
  • Certification: GMP, ISO 9001, USP, BP
  • State: Powders
  • Alias: Tacrolimus
  • Trademark: NJBN
  • Specification: 25kg/drum
  • HS Code: 2904203000
Product Description
Anti-Inflammatory Pharmaceutical Intermediates Immunosuppressor 104987-11-3 Tacrolimus

Tacrolimus 
Tacrolimus CAS: 104987-11-3 
Tacrolimus MF: C44H69NO12 
Tacrolimus MW: 804.02 
Product Categories: Active Pharmaceutical Ingredients;Immunosuppressant;Intermediates & Fine Chemicals;Pharmaceuticals;API;Chiral Reagents;Fujimycin ;antibiotic 
Mp  113-115°C 
Storage temp.  -20°C
Solubility  DMSO: >3 mg/mL
Form  solid
Color  white
Chemical Properties White Crystalline Solid 
Usage An immunosuppressant that blocks T cell proliferation in vitro by inhibiting the generation of several lymphokines, especially IL-2. Shown to inhibit the activity of FK-506 binding protein, thereby reversing its effects on sarcoplasmic reticulum Ca+2 release. 
Usage FK-506 (Tacrolimus) is a macrolide immunosuppressive drug that is mainly used after allogeneic organ transplant to reduce the activity of the patient's immune system 
Usage Tacrolimus (fujimycin) was discovered as a potent inhibitor of IL2 production in a targeted search for novel immunosuppressants. Tacrolimus acts by blocking T cell proliferation in vitro by inhibiting the generation of several lymphokines, notably the original target IL-2. Tacrolimus inhibits the activity of FK-506 binding protein, Ca2+-dependent phosphatase and calcineurin, and activates NF-κB through phosphorylation and degradation of IκBα. 
Usage treatment of Cushing's syndrome 
Usage For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was first approved by the FDA in 1994 for use in liver transplantation, this has been extended to include kidney, heart. 
 
Product NameCAS
PICEATANNOL10083-24-6
Ursodeoxycholic acid128-13-2
Moxidectin113507-06-5
Intedanib656247-17-5
Regorafenib755037-03-7
Galantamine Hydrobromide1953-04-4
Dabrafenib (GSK2118436)1195765-45-7
Chenodeoxycholic acid474-25-9
Hyaluronic acid9004-61-9
Amstat1197-18-8
Metronidazole443-48-1
Clotrimazole23593-75-1
Memantine hydrochloride41100-52-1
Pregabalin148553-50-8
Phenibut1078-21-3
Baclofen1134-47-0
D(+)-Glucose50-99-7
Piperonyl butoxide51-03-6
D-(+)-Mannose3458-28-4
GENIPIN(RG)6902-77-8
Chlorhexidine acetate56-95-1
Theophylline58-55-9
N-METHYLPYRROLIDNONE872-50-4
Tacrolimus104987-11-3
Send your message to this supplier
Avatar
Mr. Cpss
WhatsApp:+8617327093119
*From:
To: Mr. Cpss
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category